Clinical Trial Update: Low Dose Vasopressin in Traumatic Shock [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial investigating low-dose vasopressin for traumatic shock has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Injuries
• Traumatic Shock

Drugs mentioned

• VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Injuries, Shock, Traumatic | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2013-04-16